This was the key figure in a Nature Medicine paper published on Dec 14, 2021. It showed clearly that myocarditis after vaccination (in this case, Moderna dose 2) was higher! than myocarditis after sars-cov-2 infection for people <40.
This was the key figure in a Nature Medicine paper published on Dec 14, 2021. It showed clearly that myocarditis after vaccination (in this case, Moderna dose 2) was higher! than myocarditis after sars-cov-2 infection for people <40.
